Eisai seeks UK Approval for Insomnia Therapy Lemborexant
Eisai has submitted lemborexant for regulatory review in the UK, aiming to expand treatment options for adults suffering from chronic insomnia and improve patients' daytime functioning.
Eisai Co | 04/07/2026 | By News Bureau
The four companies will aim to promote the use of more environmentally friendly packaging for pharmaceutical products by sharing knowledge on packaging technologies
Eisai Co | 22/12/2022 | By Sudeep Soparkar | 1045
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy